3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Burkitt Lymphoma
11
Recurrence
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Biphenotypic, Acute
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Waldenstrom Macroglobulinemia
2
Smoldering Multiple Myeloma
2
Neoplasm Metastasis
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Lung Neoplasms
2
Leukemia
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm, Residual
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Plasma Cell
1
Interventions
Gemcitabine
29
pembrolizumab
20
Cisplatin
20
Magnetic Resonance Spectroscopy
17
Specimen Handling
16
Mitomycin
10
enfortumab vedotin
9
durvalumab
9
Cystoscopy
9
avelumab
8
Nivolumab
8
Fluorouracil
8
Carboplatin
8
Radiation
7
Cystectomy
6
atezolizumab
5
Transurethral Resection of Bladder
5
Radiotherapy
5
Mitozytrex
5
Docetaxel
5
Biopsy
5
tremelimumab
4
sacituzumab govitecan
4
erdafitinib
4
dehydroftorafur
4
Platinum
4
Immunoglobulin G
4
Disulfides
4
1,2-diaminocyclohexaneplatinum II citrate
4
disitamab vedotin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Calcium Dobesilate
×
90 days
×
Clear all
No trials found.